New Edge Advisors, LLC Invitae Corp Transaction History

New Edge Advisors, LLC

  • $11.2 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$0.42 - $0.72 $5,722 - $9,809
13,624 Added 865.02%
15,199 $9,000
Q2 2023

Aug 14, 2023
SELL
$1.05 - $1.63 $480 - $746
-458 Reduced 22.53%
1,575 $1,000
Q1 2023

May 12, 2023
SELL
$1.2 - $2.73 $4,549 - $10,349
-3,791 Reduced 65.09%
2,033 $2,000
Q4 2022

Feb 14, 2023
BUY
$1.71 - $3.61 $9,959 - $21,024
5,824 New
5,824 $10,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email